Choosing a hypomethylating agent in MDS: does gender matter?

Taylor and Francis Group, Leukemia & Lymphoma, 6(58), p. 1277-1278

Journal article published in 2017 by Matthieu Duchmann

, Raphael Itzykson

This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Preprint: archiving forbidden

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by